Synch acted as legal advisor to AlzeCure Pharma. The board of directors for AlzeCure Pharma has resolved a rights issue of approximately SEK 53 million. In...
AlzeCure Pharma’s Rights Offering
Kebni’s Private Placement
Synch Advokat advised Kebni on the deal. Kebni AB (publ), a company listed on Nasdaq First North Growth Market, completed the issuance of new shares of series...
Cortus Energy’s Rights Offering
Synch acted as legal advisor to Cortus on the deal. Cortus Energy AB, listed on Nasdaq First North Growth Market, carried out a rights issue of...
Qred’s Obtaining a Banking License
Hammarskiöld has advised Qred on the deal. Qred has been granted a license to conduct banking operations. Qred is a leading financier of small businesses in the...
Nstart AB’s Obtaining SFSA License to Become a Credit Institution
Hammarskiöld assisted Nstart in the transaction. Swedish fintech Nstart AB has been licensed to operate as a credit institution by the Swedish Financial Supervisory Authority (the...
KebNi’s SEK 85.7 Million Shares Offering And Private Placement
Synch Law advised KebNi on the deal. The board of Nasdaq First North-listed Kebni AB (publ) has published a decision on a right issue of units...